FDA Hints J&J Booster Jab May Be Beneficial, But Remains Mum On Approval Odds
With just one day left before the FDA’s vaccine advisory committee meets in person to discuss booster-jab submissions from Moderna and J&J, the FDA has just shunned Moderna once again by suggesting that the agency might approve the J&J booster jab, one day after it suggested that Moderna’s jab is still “too effective” to justify recommending a third jab.